Israeli startup RealView Imaging offers innovations in medtech that use holographic imaging. Their HOLOSCOPE-I just got FDA approval. And RealView has also brought in an additional $5 million in funding from the Lowy Medical Research Institute and Rami Ungar to complete a $15 million Series C round.
RealView Imaging is pioneering the field of interactive live holography, creating a new dimension for medical imaging applications. The company’s proprietary Digital Light Shaping technology provides physicians with a unique natural user experience, creating the only accurate, three-dimensional holograms within hands reach.
There was an episode of Star Trek the Next Generation where Warf breaks his back. So Dr. Crusher had to perform a risky operation to repair the damage.
Will you offer us a hand? Every gift, regardless of size, fuels our future.
Your critical contribution enables us to maintain our independence from shareholders or wealthy owners, allowing us to keep up reporting without bias. It means we can continue to make Jewish Business News available to everyone.
You can support us for as little as $1 via PayPal at firstname.lastname@example.org.
In that episode, we see her preparing for surgery by reviewing a #D holographic image of Warf’s spine. Warf is a Klingon, so the special effects people did their job well, providing the audience with a realistic recreation of a Klingon spine. Well, this is kind of like what RealView Imaging offers.
RealView Imaging states that their HOLOSCOPE-i system has been designed and tailored to the specific needs of clinicians and interventionalists, with an “over-the-head” system configuration suspended above the physician, without the need for any head-mounted device, special eyewear or interaction tools.
Based on the company’s proprietary Digital Light Shaping technology, the HOLOSCOPE-I, boasts RealView, is the only commercial product which “employs true interference-based volumetric holography (a Nobel Prize winning technology) to create holograms with high spatial resolution in all three dimensions. This unique technological advantage allows natural 3D/4D visualization and prolonged use of the system without provoking fatigue, nausea or headache, which are the major problems with all currently available 3D stereoscopic visualization solutions, including Augmented Reality headsets, Virtual Reality headsets and stereoscopic screens.”
“There is a rapidly growing need for advanced visualization solutions in the world of Medical Imaging, driven by the huge trend to perform minimally-invasive procedures that exclusively rely on imaging technologies,” says Shaul Gelman, CEO and Co-Founder of RealView Imaging. “The HOLOSCOPE™-i delivers the next-generation of 3D interactive visualization tools that empower imaging-based medical interventions, allowing clinicians to intuitively understand the complex anatomy they are treating in a realistic and accessible way like never seen before.”
“After years of developing this incredible deep-technology, we are excited to bring this science-fiction solution to support real-world clinical practice,” said Dr. Shimon Eckhouse, RealView’s Chairman of the Board. “Following this important FDA clearance, we are now focused on the commercialization of the HOLOSCOPE™-i system in North America and are planning to expand our market reach to additional countries over the next year. I believe RealView can significantly impact the growing field of structural heart interventions, as well as additional clinical fields which rely on advanced imaging to deliver better and faster medical care.”